Results 201 to 210 of about 1,930,566 (331)
ABSTRACT Background Plasma p‐tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p‐tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MCI) and subjective cognitive decline (SCD).
Giulia Giacomucci+12 more
wiley +1 more source
Direct generation of 1O2 in living tissues for the treatment of brain diseases. [PDF]
Semyachkina-Glushkovskaya O.
europepmc +1 more source
Sphingomyelinases in Human Tissues. II. Absence of a Specific Enzyme from Liver and Brain of Niemann-Pick Disease, Type C [PDF]
John W. Callahan+2 more
openalex +1 more source
Moyamoya Disease and the Risk of Parkinson's Disease
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo+9 more
wiley +1 more source
Reversibility of Tumor-like Lesions: Meticulous Diagnosis for Treatable Brain Diseases. [PDF]
Hsieh ST.
europepmc +1 more source
ART. XV.—The Human Brain; its Structure, Physiology and Diseases, with a Description of the Typical Forms of Brain in the Animal Kingdom [PDF]
Samuel Solly
openalex +1 more source
Change in Cognition Following Ischaemic Stroke
ABSTRACT Objective Cognitive decline can occur following ischaemic stroke. How cognition changes over time and associations with cognitive change are poorly understood. This study aimed to explore these issues over 2 years following ischaemic stroke.
Wenci Yan+8 more
wiley +1 more source
Human cerebral organoids: Complex, versatile, and human-relevant models of neural development and brain diseases. [PDF]
Coronel R+10 more
europepmc +1 more source